• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Orexigen Therapeutics Inc

+ Add to Watchlist

JXS:GR

3.654 EUR 0.011 0.30%

As of 02:08:33 ET on 04/16/2014.

Snapshot for Orexigen Therapeutics Inc (JXS)

Open: 3.668 Day's Range: 3.654 - 3.668 Volume: 0
Previous Close: 3.665 52wk Range: 3.420 - 5.840 1-Yr Rtn: -17.44%

Stock Chart for JXS

No chart data available.
  • JXS:GR 3.654
  • 1M
  • 1Y
3.665
Interactive JXS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for JXS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 44.7469
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.1130
Est. PEG Ratio -
Market Cap (M EUR) 407.56
Shares Outstanding (M) 111.54
30 Day Average Volume 7
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for JXS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for JXS

Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system, or CNS, disorders with an initial focus on obesity.

Michael Narachi "Mike"President/CEOMark D BoothChief Commercial Officer
Joseph P Hagan "Jay"Chief Bus Officer/Acting CFOHeather D TurnerSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for JXS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil